AGEN Stock Quote

Antigenics Inc. Q2 2010 Earnings Call Transcript

Thu, 29 Jul 2010 18:59:13 GMT

(at Seeking Alpha)

Q2 2010 Antigenics Inc. Earnings Release - Before Market Open

Thu, 29 Jul 2010 11:07:24 GMT

(CCBN)

ANTIGENICS INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib

Thu, 29 Jul 2010 11:03:37 GMT

(EDGAR Online)

Antigenics Reports Second Quarter 2010 Financial Results
LEXINGTON, Mass.----Antigenics Inc. reported today its results for the quarter ended June 30, 2010. The company incurred a net loss attributable to common stockholders of $5.2 million, or $0.05 per share, basic and diluted, for the second quarter of 2010, compared with a net loss attributable to common stockholders of $12.3 million, or $0.17 per share, basic and diluted, in the second quarter of 2009.

Thu, 29 Jul 2010 11:00:00 GMT

(Business Wire)

Antigenics Inc. is Today's Focus Stock on MicroStockProfit.com
DALLAS -- MicroStockProfit.com announces an investment report featuring Antigenics Inc. . The report includes financial, comparative and investment analyses, and recent company news that you need to know to make an educated investment decision.

Wed, 28 Jul 2010 10:50:00 GMT

(GlobeNewswire)

Antigenics: Bright Future Ahead

Wed, 28 Jul 2010 07:45:42 GMT

(at Seeking Alpha)

Good early results for herpes vaccine

Tue, 27 Jul 2010 19:05:11 GMT

(at bizjournals.com)

Antigenics posts positive herpes drug study data
Antigenics reported positive data Tuesday from an early stage clinical therapy trial to treat herpes simplex virus-2, the virus that causes genital herpes.

Tue, 27 Jul 2010 18:31:20 GMT

(AP)

Antigenics shares up on progress with herpes drug

Tue, 27 Jul 2010 15:43:47 GMT

(at MarketWatch)

Antigenics Presents Positive, Top Line Data from Phase I Herpes Clinical Trial
SALT LAKE CITY----Antigenics announced positive results with AG-707, an investigational therapeutic vaccine being developed to treat herpes simplex virus-2 , the virus that causes genital herpes, in infected patients.

Tue, 27 Jul 2010 11:00:00 GMT

(Business Wire)